Total Payments
$16,628
2024 Payments
$4,431
Companies
70
Transactions
746
Medicare Patients
883
Medicare Billing
$69,657
Payment Breakdown by Category
Food & Beverage$14,413 (86.7%)
Travel$1,516 (9.1%)
Education$356.88 (2.1%)
Gifts$342.44 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,413 | 702 | 86.7% |
| Travel and Lodging | $1,516 | 4 | 9.1% |
| Education | $356.88 | 22 | 2.1% |
| Gift | $342.44 | 18 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTISSUE HOLDINGS INC. | $2,702 | 23 | $0 (2024) |
| ABBVIE INC. | $1,509 | 76 | $0 (2024) |
| Astellas Pharma US Inc | $1,304 | 62 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,270 | 88 | $0 (2024) |
| Novo Nordisk Inc | $1,205 | 69 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $598.21 | 22 | $0 (2019) |
| Allergan, Inc. | $552.82 | 71 | $0 (2022) |
| IRONWOOD PHARMACEUTICALS, INC | $488.11 | 32 | $0 (2024) |
| Aspira Women's Health Inc | $487.75 | 2 | $0 (2021) |
| Sumitomo Pharma America, Inc. | $442.24 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,431 | 86 | BIOTISSUE HOLDINGS INC. ($2,675) |
| 2023 | $1,940 | 76 | Sumitomo Pharma America, Inc. ($301.55) |
| 2022 | $1,714 | 91 | ABBVIE INC. ($412.87) |
| 2021 | $2,335 | 105 | Aspira Women's Health Inc ($487.75) |
| 2020 | $1,351 | 86 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($209.10) |
| 2019 | $1,613 | 114 | Astellas Pharma US Inc ($273.18) |
| 2018 | $1,632 | 103 | AMAG Pharmaceuticals, Inc. ($363.21) |
| 2017 | $1,613 | 85 | Novo Nordisk Inc ($196.80) |
All Payment Transactions
746 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $282.76 | General |
| 12/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $36.19 | General |
| 12/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $27.15 | General |
| 12/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $22.99 | General |
| 12/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $19.29 | General |
| 12/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Biological | ||||||
| 12/10/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $19.29 | General |
| 12/08/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.64 | General |
| Category: GI | ||||||
| 11/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $36.19 | General |
| 11/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $22.99 | General |
| 11/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $282.76 | General |
| 11/21/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $27.15 | General |
| 11/20/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $107.96 | General |
| Category: Neurology | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Innovation Technologies Inc | IRRISEPT (Device) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: JET LAVAGE DEVICE WITH CHG | ||||||
| 11/07/2024 | Gynesonics, Inc. | SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM | ||||||
| 11/04/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Oncology | ||||||
| 10/28/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $143.46 | General |
| 10/25/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/22/2024 | BIOTISSUE HOLDINGS INC. | — | Travel and Lodging | Cash or cash equivalent | $787.95 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 239 | 338 | $36,241 | $18,984 |
| 2022 | 4 | 142 | 227 | $26,164 | $16,226 |
| 2021 | 5 | 272 | 361 | $32,685 | $19,727 |
| 2020 | 6 | 230 | 291 | $26,480 | $14,720 |
Total Patients
883
Total Services
1,217
Medicare Billing
$69,657
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 141 | $14,805 | $7,410 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 46 | $6,072 | $3,852 | 63.4% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 39 | 44 | $6,714 | $3,114 | 46.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $3,533 | $1,714 | 48.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 44 | 44 | $2,860 | $1,576 | 55.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 17 | 19 | $2,185 | $1,264 | 57.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 16 | 18 | $72.00 | $54.56 | 75.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 122 | $12,000 | $6,871 | 57.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 53 | $6,809 | $4,455 | 65.4% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 32 | 33 | $4,305 | $2,593 | 60.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $3,050 | $2,307 | 75.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 176 | $13,200 | $9,155 | 69.4% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 38 | 44 | $7,040 | $3,800 | 54.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 61 | 61 | $4,575 | $2,430 | 53.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 63 | 63 | $4,725 | $2,302 | 48.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $3,145 | $2,040 | 64.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 84 | 142 | $10,650 | $6,470 | 60.7% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 34 | 37 | $5,920 | $3,005 | 50.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 22 | 22 | $4,070 | $2,244 | 55.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 40 | 40 | $3,000 | $1,494 | 49.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 37 | 37 | $2,775 | $1,463 | 52.7% |
| 81002 | Urinalysis, manual test | Office | 2020 | 13 | 13 | $65.00 | $44.68 | 68.7% |
About Dr. Magdalene Karon, MD
Dr. Magdalene Karon, MD is a Specialist healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730194978.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Magdalene Karon, MD has received a total of $16,628 in payments from pharmaceutical and medical device companies, with $4,431 received in 2024. These payments were reported across 746 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($14,413).
As a Medicare-enrolled provider, Karon has provided services to 883 Medicare beneficiaries, totaling 1,217 services with total Medicare billing of $69,657. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Obstetrics & Gynecology
- Location Lexington, KY
- Active Since 07/29/2006
- Last Updated 10/01/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730194978
Products in Payments
- TRULANCE (Drug) $1,112
- Saxenda (Drug) $898.30
- LINZESS (Drug) $724.72
- INTRAROSA (Drug) $615.11
- MYRBETRIQ (Drug) $573.92
- LO LOESTRIN FE (Drug) $530.96
- OVA1 (Device) $487.75
- GEMTESA (Drug) $483.98
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) $433.70
- Linzess (Drug) $426.11
- Trulance (Drug) $308.03
- Myrbetriq (Drug) $273.67
- Veozah (Drug) $262.09
- ANNOVERA (Drug) $259.47
- Wegovy (Drug) $254.28
- Da Vinci Surgical System (Device) $247.50
- SLYND (Drug) $243.59
- CREON (Drug) $226.42
- MYFEMBREE (Drug) $212.58
- APTIMA (Device) $204.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Lexington
Dr. Steven Waldman, M.d, M.D
Specialist — Payments: $119,557
Specialist $119,557
June Yong, Md, MD
Specialist — Payments: $12,010
Specialist $12,010
Dr. Warren Frank, Md, MD
Specialist — Payments: $9,353
Specialist $9,353
Mr. Joseph Bark, M.d, M.D
Specialist — Payments: $7,101
Specialist $7,101
Dr. Samy Elayi, Md, MD
Specialist — Payments: $5,948
Specialist $5,948
Dr. James Dewar, M.d, M.D
Specialist — Payments: $5,759
Specialist $5,759